[144] BKV Corporation SEC Filing

Rhea-AI Filing Summary

BKV Corporation (BKV) filed a Form 144 disclosing a proposed sale of 9,187 common shares through Charles Schwab & Co., to be executed on 09/02/2025, with an aggregate market value of $212,984 based on the filing. The shares were originally acquired as founders shares on 05/01/2020 from BKV Corp. The filing also reports three prior sales by the same seller in the past three months: 10,000 shares on 06/02/2025 for $216,485, 10,000 shares on 07/01/2025 for $231,307, and 10,000 shares on 08/12/2025 for $216,200. The form includes the statutory signature and representations required by Rule 144.

Insights

Securities Analyst

TL;DR: Routine insider sale disclosure; transaction sizes are small relative to outstanding shares and provide transparency on recent disposals.

The Form 144 reveals a proposed sale of 9,187 founder shares valued at $212,984 and documents three prior monthly disposals of 10,000 shares each in June, July, and August 2025. From a market-impact perspective, the amounts represent a very small fraction of the reported 84,711,220 shares outstanding, suggesting limited dilution or price impact. The filing properly identifies the broker and acquisition provenance, which supports regulatory compliance and investor transparency.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements; repeated sales by the same person warrant monitoring but show formal compliance.

The document certifies the seller's representation about material nonpublic information and cites a broker arrangement for execution. It records founder-share origin and dates, satisfying Rule 144 disclosure elements. While the seller conducted multiple transactions in the prior three months, the filing contains the necessary attestations and signature language, indicating adherence to reporting obligations rather than an immediate governance concern.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	9187	212984.00	84711220	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2020	Founders Shares	BKV Corp			9187	05/01/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lindsay B Larrick 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	06/02/2025	10000	216485.00
Lindsay B Larrick 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	07/01/2025	10000	231307.00
Lindsay B Larrick 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	08/12/2025	10000	216200.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BKV Form 144 disclose about proposed insider sales?

The filing discloses a proposed sale of 9,187 common shares on 09/02/2025 through Charles Schwab with an aggregate market value of $212,984.

Who acquired the shares being sold and when (BKV)?

The shares were acquired as founders shares on 05/01/2020 from BKV Corp, as stated in the filing.

Has the seller sold BKV shares recently?

Yes. The filing reports three sales in the past three months: 10,000 shares on 06/02/2025 for $216,485, 10,000 shares on 07/01/2025 for $231,307, and 10,000 shares on 08/12/2025 for $216,200.

What broker is handling the proposed BKV sale?

The proposed sale is to be executed through Charles Schwab & Co., Inc. (address shown in the filing).

How large is the proposed sale relative to BKV's outstanding shares?

The filing lists 84,711,220 shares outstanding; the proposed sale of 9,187 shares is a very small fraction of that total.